2-(Difluoromethoxy)-1-fluoro-3-iodobenzene

Catalog No.: 
ACNGBA623
CAS No.: 
1261763-19-2
Molecular Formula: 
C7H4F3IO
Molecular Weight: 
288.01
2-(Difluoromethoxy)-1-fluoro-3-iodobenzene structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$272.00InquiryInquiry
1g95%$679.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Difluoromethoxy)-1-fluoro-3-iodobenzene
IUPAC Name2-(difluoromethoxy)-1-fluoro-3-iodobenzene
MDL No.MFCD18396810
Molecular FormulaC7H4F3IO
Molecular Weight288.01
SMILESIC1=C(C(F)=CC=C1)OC(F)F
InChI KeyOIUMLVHKRRMEDO-UHFFFAOYSA-N
Synonym2-(difluoromethoxy)-1-fluoro-3-iodobenzene;Benzene, 2-(difluoromethoxy)-1-fluoro-3-iodo-
CAS No.1261763-19-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACNGBA623 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLNBK758 route compound structure diagram
    ACLNBK75828177-50-6In Stock
  4. Then
  5. ACNGBA623 route product structure diagram
    ACNGBA6231261763-19-2
Inquiry

2. ACNGBA623 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLNBK758 route compound structure diagram
    ACLNBK75828177-50-6In Stock
  4. Then
  5. ACNGBA623 route product structure diagram
    ACNGBA6231261763-19-2
Inquiry

3. ACNGBA623 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLNBK758 route compound structure diagram
    ACLNBK75828177-50-6In Stock
  4. Then
  5. ACNGBA623 route product structure diagram
    ACNGBA6231261763-19-2
Inquiry

Comments (0)